Connecting withCritical Care
Alere Triage® NGAL Test
IDENTIFY AKI NOW instead of days from now.
A new aid to diagnosis that improves assessment of AKI beyond creatinine alone.
Acute Kidney Injury (AKI) is a serious medical challenge. It can be difficult to detect early in a patient’s clinical presentation and is associated with poor prognosis. Early recognition of renal injury is crucial and may help prevent further renal damage and functional impairment 4
The Alere Triage® NGAL Test is a point-of-care fluorescence immunoassay to be used with the Triage® Meters for the rapid, quantitative determination of Neutrophil Gelatinase Associated Lipocalin (NGAL) in EDTA anticoagulated whole blood or plasma specimens.
NGAL Levels dramatically increase in response to renal ischemia within 2 hours of injury, where it is believed to play a role in repair and nephrogenesis.9
In comparison, serum creatinine, the most commonly used functional marker for the diagnosis of AKI, does not rise until 24-72 hours after the initial renal insult.4
For more information on how this product can be used in clinical practice and for full references click on the download tab below
Alere Triage® NGAL Test is for use with the Alere Triage® MeterPro
To enquire about a specific product click the icon next to the listing below.
Save time: Register here and avoid having to re-enter your information when making multiple product enquiries. If you already have an account please login to the left.
Important Note: Unless stated otherwise we are only able to deal with UK enquiries. For enquiries outside the UK please refer to www.alere.com for a distributor in your area.
|Cat No||Description||Pack Size||Enquire|
|98430EU||Alere Triage NGAL Test||25 Tests|
|98423EU||Alere Triage Cardiorenal Control 1||5 x 0.25ml|
|98424EU||Alere Triage Cardiorenal Control 2||5 x 0.25ml|